STAT Plus: Alzheimer’s patients didn’t decline after getting a cocktail derived from young blood, but big questions remain By REBECCA ROBBINS

STAT Plus: Alzheimer’s patients didn’t decline after getting a cocktail derived from young blood, but big questions remain

By REBECCA ROBBINS

ALKAHEST

Big questions remain about the treatment from Silicon Valley firm Alkahest, but it at least appeared safe in a Phase 2 study.

READ MORE